TEL AVIV, Israel, Feb. 5, 2018 /PRNewswire/ -- Leading international medical cannabis experts from around the world will
Innovative Israeli researchers and scientists, high tech experts and "Start-Up Nation" entrepreneurs have fused their knowledge and skills with other world leaders in the industry to develop cutting-edge expertise that will be on display in the best known international gathering of its kind. A special VIP tour will take place on March 21.
Major Summit topics will include Agricultural Research, Regulation, Medical Research, Investment, Media/New Cannabis Communication, Innovation, Hemp, and Sustainability.
Economists foresee the potential overall market worth of cannabis related goods and products in the tens of billions of dollars in the next decade. At CannaTech attendees will hear from and meet the industry's most serious thought leaders and market disrupters from around the world including:
Dr. Adi Aran, initiator and lead researcher of the world's first clinical study on the efficacy & safety of cannabis for autism. Dr. Aran serves as a consultant to the Ministry of Health for medical cannabis, indications and use in children and spends much time educating physicians and lay audiences on the subject.
Vivian Bercovici, Managing Director, Europe and Israel, Nuuvera. Nuuvera is a global cannabis company founded on Canadian principles and built with the whole world in mind. Nuuvera is currently working with partners in Germany, Israel and Italy, and is exploring opportunities in several other countries, to develop commercial production and global distribution of medical grade cannabis in legalized markets.
Steve DeAngelo, co-founder and President of the Arcview Group, the world's largest cannabis industry investment group that provides financing for cannabis related businesses and projects through its network of investor members.
Bob Hoban, Managing Partner at Hoban Law Group, the America's leading cannabusiness law firm. Hoban is recognized as one of the leading commercial cannabis practitioners, representing private and publicly-held clients in numerous American states and abroad.
Lynn Honderd, co-founder and Chief Executive Officer of Mary's Medicinals, Mary's Nutritionals and Mary's Pets. Since 2013, Mary's has been leading the industry as a pioneer of cannabis delivery methods. Honderd has been instrumental in positioning Mary's as one of America's most innovative and fastest growing companies in its sector.
Dr. Dedi Meiri, Assistant Professor, Genetics and Cell Biology and heads the "Laboratory of Cancer Biology and Cannabinoid Research" at Technion, Israel Institute of Technology. Dr. Meiri operates the "Cannabis Database Project" and his lab is currently involved in several clinical trials involving diverse aspects of cannabis treatment.
Chuck Rifici, founder of Canada's Canopy Growth, recognized as one of the world's leading diversified cannabis companies with over half a million square feet of production capacity and CEO of Nesta, a private equity firm that builds partnerships and brands within the cannabis space.
Jeanne M. Sullivan, Venture Capitalist, and co-founder of StarVest partners. Sullivan is now a high-profile cannabis advocate and advisor to cannabis investors. A sought-after public speaker, she believes women can dominate the new multi-billion-dollar industry.
To learn more about the CannaTech Innovation Summit, purchase tickets and subscribe to event updates and speakers lists click here. To learn about iCAN, the Summit's organizers, click here for the iCAN website.
For further information about media coverage, interviewing CannaTech organizers and speakers or for press registration contact Laura Kam, email@example.com; +972-54-806-8613.
View original content:http://www.prnewswire.com/news-releases/leading-international-medical-cannabis-experts-from-science--business-to-highlight-cannatech-2018-300593400.html
Subscribe to our Free Newsletters!
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All